ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,021.63
0.57%
US Tech 100
20,367.60
0.51%
다우존스 지수
44,860.31
0.28%
Bitcoin
92,416.98
0.49%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC

  6. UCB (PK) (UCBJY) 시세

UCB (PK)

UCB (PK) (UCBJY)

USOTC
95.37
-1.08
(-1.12%)
마감 27 11월 6:00AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
95.37
매수가
93.76
매도가
97.06
거래량
6,813
95.12 일간 변동폭 95.98
36.7025 52주 범위 99.40
market_cap
36.163B
전일 종가
96.45
개장가
95.98
최근 거래 시간
27
@
95.37
마지막 거래 시간
재정 규모
US$ 650,030
VWAP
95.4102
평균 볼륨(3m)
20,119
발행 주식
379,189,796
배당수익률
0.97%
주가수익률
201.47
주당순이익(EPS)
0.9
매출
4.87B
순이익
343M

UCB (PK) 정보

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

섹터
Pharmaceutical Preparations
산업
Chemicals & Allied Products
웹사이트
www.ucb.com
본부
Brussels, Brussels-capital Region, Bel
설립됨
1928
UCB (PK) is listed in the Pharmaceutical Preparations sector of the OTC 시장 with ticker UCBJY. The last closing price for UCB (PK) was US$96.45. Over the last year, UCB (PK) shares have traded in a share price range of US$ 36.7025 to US$ 99.40.

UCB (PK) currently has 379,189,796 shares in issue. The market capitalisation of UCB (PK) is US$36.57 billion. UCB (PK) has a price to earnings ratio (PE ratio) of 201.47.

UCBJY 최신 뉴스

추가 뉴스

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services Judges highlight value-added partnership and finance transformation as leading examples of innovation in...

01 7월 2015
PR Newswire (US)

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S.

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S. Results of retrospective analysis show use of newer anti-epilepsy drugs, access to...

16 6월 2015
PR Newswire (US)

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015 PR Newswire ATLANTA, May 16, 2015 ATLANTA, May 16, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company...

16 5월 2015
PR Newswire (US)

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam - Major milestone for brivaracetam is latest step towards UCB goal of extending treatment...

21 1월 2015
PR Newswire (US)

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annua...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annual Meeting PR Newswire ATLANTA, Dec. 8, 2014 ATLANTA, Dec. 8, 2014...

09 12월 2014
PR Newswire (US)

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy -- Primary efficacy and safety...

08 12월 2014
PR Newswire (US)

UCB, Georgia Institute of Technology Partner to Harness the Power of Predictive Analytics in Epilepsy Care

UCB, Georgia Institute of Technology Partner to Harness the Power of Predictive Analytics in Epilepsy Care - Atlanta-based Collaboration Will Explore the Potential of Big Data to Help Inform...

04 12월 2014
PR Newswire (US)

UCB reinforces its leadership in epilepsy at the 2014 Annual Meeting of the American Epilepsy Society (AES)

UCB reinforces its leadership in epilepsy at the 2014 Annual Meeting of the American Epilepsy Society (AES) - 24 UCB-sponsored presentations including new data on VIMPAT® (lacosamide) - First...

03 12월 2014
PR Newswire (US)

UCB shows strong scientific presence at leading rheumatology meeting

UCB shows strong scientific presence at leading rheumatology meeting -- Data to be presented at the ACR/ARHP Annual Meeting on UCB's marketed product CIMZIA® (certolizumab pegol) and the...

14 11월 2014
PR Newswire (US)

Advent International and Avista Capital Partners to Acquire Kremers Urban Pharmaceuticals from UCB

Advent International and Avista Capital Partners to Acquire Kremers Urban Pharmaceuticals from UCB PR Newswire BOSTON and NEW YORK, Nov. 7, 2014 BOSTON and NEW YORK, Nov. 7, 2014 /PRNewswire/...

07 11월 2014
PR Newswire (US)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
18.649.9619508820586.7396.7286.711337291.95859896DR
4-1.9-1.9533257941897.2799.486.712158196.17314609DR
126.216.9650067294889.1699.486.712011994.16093896DR
2626.2838.037342596669.0999.468.2451905585.85108277DR
5257.37150.9736842113899.436.70251816772.28026001DR
15638.7368.379237288156.6499.432.822121950.86785363DR
26055.12136.94409937940.2599.432.452012152.20249678DR

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TMPOQTempo Automation Holdings Inc (CE)
US$ 0.005
(499,900.00%)
100
FUNFFFansUnite Entertainment Inc (CE)
US$ 0.0006
(59,900.00%)
268.14k
SWWISimon Worldwide Inc (GM)
US$ 0.0005
(49,900.00%)
300
AMMJAmerican Cannabis Company Inc (CE)
US$ 0.0004
(39,900.00%)
7.45k
MGTIMGT Capital Investments Inc (CE)
US$ 0.0002
(19,900.00%)
261.83k
CRMBQCrumbs Bake Shop Inc (CE)
US$ 0.000001
(-99.99%)
200
EMWPFEros Media World PLC (CE)
US$ 0.000001
(-99.95%)
100
CNONFLynx Global Digital Finance Corporation (CE)
US$ 0.000001
(-99.90%)
1.85k
DEERDeer Consumer Products Inc (CE)
US$ 0.000001
(-99.90%)
3.6k
CAFSCafe Serendipity Holdings Inc (CE)
US$ 0.000001
(-99.50%)
5k
HMBLHUMBL Inc (PK)
US$ 0.0003
(20.00%)
151.08M
ABQQAB International Group Corporation (PK)
US$ 0.001
(25.00%)
142M
THBDThird Bench Inc (PK)
US$ 0.0001
(0.00%)
128.56M
RDARRaadr Inc (PK)
US$ 0.001
(0.00%)
109.04M
ASTAAstra Veda Corporation (PK)
US$ 0.0002
(0.00%)
93.24M

토론

전체 피드 보기
MDPennyPlayer MDPennyPlayer 5 분 전
That's impossible, everyone said I wasn't a shareholder so how could I sell? Lol. Make up your minds
SHMN
StayHumble StayHumble 5 분 전
Full YEAR SALES $55M+Up90%✅✅GrossProfit $20M+Up 99%✅✅
https://www.healthiercmc.com/news/240327-hcmc-q4-2023-results
HCWC
MrTrader129 MrTrader129 6 분 전
Lets say NLST gets paid on all the lawsuits. Do they have a proper business model moving forward?
NLST
rosemountbomber rosemountbomber 7 분 전
No question ghat the Investor Conference was a big waste and let down.  None of us are happy with what the company is doing.  Problem is (outside of new formulation) the company is jammed into the 7 rolled up dimensions of space.  There is not much they can do now.  US would require legal remedies a
DTC
rbtree rbtree 8 분 전
It's beyond me how idiotic you are.
AABB
nowwhat2 nowwhat2 9 분 전
https://investorshub.advfn.com/uimage/uploads/2024/11/26/tj[[ebtc_111111_26_30d_833pm_CHAN_KEY_W_XRP.jpg

Begging the question : Just WHEN might the 100,000 get revisited ?.....Soon, or could it take a while ?....January 20th ?



Likewise / similarily - Th
BTCUSD
StayHumble StayHumble 10 분 전
$HCMC has a 4-point plan💹$5M BUYBACK💹+Dividend💹No r/s💹

-A buyback of up to $5M of $HCMC common stock.

-A spinoff of certain HCMC assets into a new publicly traded company

-A stock dividend to $HCMC shareholders of the st
HCMC
No-Quarter No-Quarter 10 분 전
Thx for the vid. I came to the understanding a while back that all coins that have a CEO, are ripe for manipulation and shenanigans.

Only coins that have no CEO to manipulate the coins value, or issue more with a hand wave, have a chance of behaving like a tradable or investable eq
amrwonderful amrwonderful 11 분 전
Shares short-3.21 Miilion-11/15/24
IDCC
Mactheriverrat Mactheriverrat 12 분 전
SGMO - Nice day and the start of another uptrend
SGMO
north40000 north40000 12 분 전
How about a M/A draft agreement, not completed, where the approved drug is consequential to the buyout price, forms part of consideration or $$$value of agreement, or even the existence of an agreement? The FDA-approved drug could be in process of being auctioned to a select group of would-be buyers
VALUE
dinogreeves dinogreeves 14 분 전
I have learned over the years not all traders know everything about trading, in-fact 97% of them don't know jack chit. Today was a proven fact with this latest filings, that no one can read filings or cares to even read filings, they are in for quick buck or two for ends meet. About couple of week
SMCI
CrossFireTrader CrossFireTrader 14 분 전
To avoid the wash you have to wait until after 31 days to buy it back is that correct ?
GDVM
Hanibal Hanibal 17 분 전
I know nothing about anything

Yeah we know. You've made that clear. That's why you're still here over a year later, hoping that a dead and deleted stock will come back to life and return you the money you lost.

It's just too gosh darn bad it's fictitious nonsense.
CrossFireTrader CrossFireTrader 18 분 전
Before 31 days of after 31 days
GDVM
EternalPatience EternalPatience 19 분 전
The watermark says capitalforum.con for what's worth to anyone
FNMA
gfp927z gfp927z 24 분 전
Xena, I wasn't implying that Cipro would have been the cause of your B-12 deficiency (if you have one). B-12 deficiencies are actually very common (see Gundry video below) -


https://www.youtube.com/watch?v=opmvTl8hvYY



---
StayHumble StayHumble 25 분 전
100% Xpert BUYS💹 wow interest is growing💹💹 https://ih.advfn.com/stock-market/USOTC/digital-brand-media-and-pk-DBMM/trades
DBMM
GoliathRulz GoliathRulz 25 분 전
I see that upward trend is still continuing. Lol. $GMER … the $hit stock that never disappoints.
GMER HIT

최근 히스토리

USOTC
UCBJY
UCB (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유